Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · Adeshwar Meditex Limited · 11 September 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
Adeshwar Meditex Limited is a Healthcare Services company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, – (all audited; no estimate years)
₹ crore · consolidated
Revenue
EBITDA (ex other income)
margin %
Owners' profit
EPS, as reported (₹)
ROE % · ROCE %
Debt / equity (x)
Cash from operations
Capex
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · Adeshwar Meditex Limited · 11 September 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 1 quarters
₹ crore
Q2 FY23
Revenue
46
Profit before tax
2
Net profit
—
EPS (₹)
0.75
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Peers — basic industry group, by market cap
Company
M.cap ₹ cr
P/E
P/B
EV/EBITDA
ROE %
ROCE %
Rev CAGR 5y %
EBITDA m. %
NOVELIX PHARMACEUTICALS LIMITE
185
—
24.92
—
(3.3)
(3.3)
—
(9.5)
Jeevan Scientific Technology L
162
18.2
2.23
15.8
1.4
2.4
5.1
21.5
GlobalSpace Technologies Limit
116
38.0
2.04
25.3
5.0
3.4
13.7
7.1
Adeshwar Meditex Limited ◆
24
21.8
—
—
—
—
—
—
Vanta Bioscience Limited
13
3.0
—
—
—
0.0
(29.0)
—
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 4: Where the company sits in its group
Metric
Company
Group median
Rank
Better than
P/E (TTM)
21.8
31.2
28 of 68
60%
Market cap
24
261
59 of 71
17%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Dossier · Adeshwar Meditex Limited · 11 September 2026Page 3 of 3
Exhibit 5: Filings of the last 90 days, with the measured price reaction
Date · filing
Category
Importance
1-day %
5-day %
29 Aug 2026 · Newspaper notice published for 19th AGM and e-voting details
compliance
minimal
—
—
27 Aug 2026 · Book closure for 19th AGM from September 17 to 23, 2026
board shareholder meetings
low
—
—
27 Aug 2026 · 19th AGM notice on Sept 23, 2026; auditor change and director appointments
board shareholder meetings
low
—
—
27 Aug 2026 · Annual Report and AGM Notice submitted for FY 2025-26
compliance
low
—
—
27 Aug 2026 · Non-Executive Director Mr. Prithvi Singh resigns citing personal commitments
management changes
medium
—
—
26 Aug 2026 · Adeshwar Meditex board outcome: new auditor, director changes, AGM set
management changes
medium
—
—
22 Aug 2026 · Board meeting on Aug 26 to approve director appointment and AGM items
management changes
medium
—
—
4 Aug 2026 · Non-Executive Director Satish Chudekar resigns citing personal commitments
management changes
medium
—
—
13 Jul 2026 · RTA confirms no dematerialisation requests in June 2026 quarter
compliance
minimal
—
—
22 May 2026 · Clarification on typographical error w.r.t amounts mentioned in Annexure III enclosed along with Outcome of Board meeting submitted on May 21, 2026
compliance
low
—
—
Source: exchange announcements; reaction = close-to-close from the filing's session.
How to read this document
Where a broker report shows
This document shows
Why
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last page
marketping.in
A rating (BUY / ADD / REDUCE / SELL)
A state: the latest filed quarter and the measured reactions
an event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upside
The current price and the multiples against the group
a target is a forecast; a multiple is a measurement
Estimate years marked E
More audited years; no estimates
MarketPing publishes no forecasts — your own model lives on the Models page
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
